AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank33
3Y CAGR-6.9%
5Y CAGR-9.7%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-6.9%/yr
vs -3.3%/yr prior
5Y CAGR
-9.7%/yr
Consistent
Acceleration
-3.6pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 2.01% | -21.0% |
| 2025 | 2.55% | -11.9% |
| 2024 | 2.89% | +15.8% |
| 2023 | 2.49% | -12.8% |
| 2022 | 2.86% | -14.7% |
| 2021 | 3.35% | +38.8% |
| 2020 | 2.42% | -15.5% |
| 2019 | 2.86% | +20.9% |
| 2018 | 2.36% | -4.7% |
| 2017 | 2.48% | - |